Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Vincristine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 192 Precursor Cell Lymphoblastic Leukemia-Lymphoma 164 Lymphoma, Large B-Cell, Diffuse 159 Leukemia 93 Burkitt Lymphoma 82 Lymphoma, Non-Hodgkin 79 Lymphoma, Follicular 72 Lymphoma, Mantle-Cell 50 Hodgkin Disease 43 Neuroblastoma 40 Central Nervous System Neoplasms 37 Sarcoma 34 Lymphoma, B-Cell 27 Lymphoma, Large-Cell, Immunoblastic 26 Lymphoma, Large-Cell, Anaplastic 26 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25 Lymphoma, T-Cell, Peripheral 24 Rhabdomyosarcoma 21 Lymphoma, B-Cell, Marginal Zone 21 Recurrence 20 Neoplasms 20 Multiple Myeloma 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Medulloblastoma 18 Brain Neoplasms 18 Sarcoma, Ewing 17 Leukemia, Biphenotypic, Acute 16 HIV Infections 16 Dendritic Cell Sarcoma, Interdigitating 16 Retinoblastoma 14

Interventions

Trastuzumab 527 Paclitaxel 501 Cyclophosphamide 482 Docetaxel 425 Capecitabine 359 Letrozole 312 Fulvestrant 276 Doxorubicin 254 Carboplatin 241 Tamoxifen 227 Anastrozole 189 exemestane 182 Radiotherapy 181 Epirubicin 179 Bevacizumab 172 Vinorelbine 151 Lapatinib 151 Gemcitabine 149 pembrolizumab 145 pertuzumab 143 palbociclib 135 Exercise 116 Albumin-Bound Paclitaxel 107 Magnetic Resonance Spectroscopy 104 Fluorouracil 104 eribulin 99 130-nm albumin-bound paclitaxel 95 Everolimus 90 Taxes 85 Cisplatin 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02299999 2025-01-15

SAFIR02_Breast

UNICANCER

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡